Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Flolan 1.5 mg Powder and Solvent for Solution for Infusion (with pH 12 solvent & Vented Vial Adaptor)

Active Ingredient:
epoprostenol sodium
Company:  
GlaxoSmithKline UK See contact details
ATC code: 
B01AC09
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Safety Alert Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Recall Notification of Flolan 1.5 mg in the UK Market

A class 2 patient level recall notification, issued by MHRA on the 22nd of July 2024 for Flolan 1.5 mg for your attention.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

GlaxoSmithKline UK
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
0800 221 441
Medical Information e-mail
[email protected]
E-mail
[email protected]
Adverse event reporting email
[email protected]